Tara McLaughlin

Hartford Hospital

Papers

7

Total Citations

109

H-Index

5

About

Dr. Tara McLaughlin is a leading researcher in urologic oncology, with a focus on optimizing surgical outcomes for prostate cancer patients. Her work centers on robotic-assisted radical prostatectomy (RARP), where she has made pivotal contributions to improving post-surgical quality of life. Notably, she led a double-blind, randomized trial demonstrating that hyperbaric oxygenation therapy can preserve erectile function after nerve-sparing prostatectomy—a groundbreaking finding with 32 citations. McLaughlin also spearheaded the PLUS trial, showing that a peritoneal iliac flap significantly reduces lymphocele formation, and has advanced venous thromboembolism risk assessment by validating the Caprini score for RARP patients. Her research extends to bariatric surgery, where she compared outcomes of robotic sleeve gastrectomy and gastric bypass using national registry data (26 citations). With over 100 collective citations across her most-cited works, McLaughlin’s rigorous clinical studies have directly shaped perioperative protocols and patient counseling. Her achievements include pioneering work on resident involvement’s impact on surgical outcomes and documenting rare complications like peritoneal carcinomatosis. For students and clinicians, McLaughlin exemplifies how translational research can enhance both oncologic control and functional recovery in robotic surgery.

Research Focus

Key Achievements

5
H-Index
7
Papers
109
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
A Double-Blind, Randomized Trial on the Efficacy and Safety of Hyperbaric Oxygenation Therapy in the Preservation of Erectile Function after Radical Prostatectomy
32 citations · 2017
📈 Most Prolific Year: 2019 (3 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Hartford Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago